Abstract:Background Breast cancer is the most common type of invasive cancer in woman. It accounts for approximately 18% of all cancer deaths worldwide. It is well known that somatic mutation plays an essential role in cancer development. Hence, we propose that a prognostic prediction model that integrates somatic mutations with gene expression can improve survival prediction for cancer patients and also be able to reveal the genetic mutations associated with survival. Method Differential expression analysis was used to identify breast cancer related genes. Genetic algorithm (GA) and univariate Cox regression analysis were applied to filter out survival related genes. DAVID was used for enrichment analysis on somatic mutated gene set. The performance of survival predictors were assessed by Cox regression model and concordance index(C-index). Results We investigated the genome-wide gene expression profile and somatic mutations of 1091 breast invasive carcinoma cases from The Cancer Genome Atlas (TCGA). We identified 118 genes with high hazard ratios as breast cancer survival risk gene candidates (log rank p < 0.0001 and c-index = 0.636). Multiple breast cancer survival related genes were found in this gene set, including FOXR2 , FOXD1 , MTNR1B and SDC1 . Further genetic algorithm (GA) revealed an optimal gene set consisted of 88 genes with higher c-index (log rank p < 0.0001 and c-index = 0.656). We validated this gene set on an independent breast cancer data set and achieved a similar performance (log rank p < 0.0001 and c-index = 0.614). Moreover, we revealed 25 functional annotations, 15 gene ontology terms and 14 pathways that were significantly enriched in the genes that showed distinct mutation patterns in the different survival risk groups. These functional gene sets were used as new features for the survival prediction model. In particular, our results suggested that the Fanconi anemia pathway had an important role in breast cancer prognosis. Conclusions Our study indicated that the expression levels of the gene signatures remain the effective indicators for breast cancer survival prediction. Combining the gene expression information with other types of features derived from somatic mutations can further improve the performance of survival prediction. The pathways that were associated with survival risk suggested by our study can be further investigated for improving cancer patient survival.

Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis

Toward Precision Breast Cancer Survival Prediction Utilizing Combined Whole Genome-Wide Expression and Somatic Mutation Analysis

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.

A Novel Coiled-Coil Domain Containing-Related Gene Signature for Predicting Prognosis and Treatment Effect of Breast Cancer.

An Integrated Model of Clinical Information and Gene Expression for Prediction of Survival in Ovarian Cancer Patients

Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis

A Metabolic Gene Signature to Predict Breast Cancer Prognosis

Integrating Single-Cell and Bulk Expression Data to Identify and Analyze Cancer Prognosis-Related Genes

Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

Tumor Microenvironment-Related Multigene Prognostic Prediction Model for Breast Cancer

Integrating of Genomic and Transcriptomic Profiles for the Prognostic Assessment of Breast Cancer

Identification and Validation of a Five-Gene Signature Associated With Overall Survival in Breast Cancer Patients

Somatic Super-Enhancer Epigenetic Signature for Overall Survival Prediction in Patients with Breast Invasive Carcinoma

Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes

Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma

The prognostic genes model of breast cancer drug resistance based on single-cell sequencing analysis and transcriptome analysis

Survival prediction model for non-small cell lung cancer based on somatic mutations.

Estrogen receptor—positive breast cancer survival prediction and analysis of resistance–related genes introduction

Prognostic Gene Expression Signature Revealed the Involvement of Mutational Pathways in Cancer Genome